Trademark: 79346405
Status Date
Tuesday, October 3, 2023
Registration Number
7178487
Registration Date
Tuesday, October 3, 2023
Filing Date
Thursday, June 9, 2022
Published for Opposition
Tuesday, July 18, 2023
5 Pharmaceutical and veterinary preparations to improve function of membranes in the body; pharmaceutical and veterinary preparations to improve function of membranes in the lung; pharmaceutical and veterinary preparations to enhance the epithelial barrier; pharmaceutical and veterinary preparations to enhance the airway epithelial barrier; pharmaceutical and veterinary preparations to inhibit inflammation; pharmaceutical and veterinary preparations for the treatment of a disease or condition that is caused by a defect in epithelial cells or tissue; pharmaceutical and veterinary preparations for the treatment of a disease or condition that benefits from enhancement or restoration of epithelial barrier function; pharmaceutical and veterinary preparations for the treatment of a disease or condition of epithelial tissue in the respiratory tract; pharmaceutical and veterinary preparations for the treatment of epithelial dysfunction; pharmaceutical and veterinary preparations for the treatment of human airway epithelial cells; pharmaceutical and veterinary preparations for the treatment of chronic respiratory diseases; pharmaceutical and veterinary preparations for the treatment of viral airways diseases; pharmaceutical and veterinary preparations for the treatment of an airways disease; pharmaceutical and veterinary preparations for the treatment of asthma; pharmaceutical and veterinary preparations for the treatment of chronic obstructive pulmonary disease (COPD); pharmaceutical and veterinary preparations for the treatment of cystic fibrosis; pharmaceutical and veterinary preparations for the treatment of non-cystic fibrosis bronchiectasis; pharmaceutical and veterinary preparations for the treatment of chronic rhinosinusitis; pharmaceutical and veterinary preparations for the treatment of diffuse panbronchiolitis (DPB); pharmaceutical and veterinary preparations for the treatment of chronic bronchitis; pharmaceutical and veterinary preparations for the treatment of bronchiolitis obliterans organizing pneumonia (BOOP); pharmaceutical and veterinary preparations for the treatment of infantile respiratory distress syndrome (IRDS); pharmaceutical and veterinary preparations for the treatment of bronchopulmonary dysplasia; pharmaceutical and veterinary preparations for the treatment of neuromuscular respiratory depression or failure; pharmaceutical and veterinary preparations for the treatment of pneumonia; pharmaceutical and veterinary preparations for the treatment of conditions caused by and associated with respiratory syncytial virus (RSV) and related viruses; pharmaceutical and veterinary preparations for the treatment of a disease or condition commonly associated with inflammation that benefits from enhancement or restoration of epithelial barrier function; pharmaceutical and veterinary preparations for the treatment of systemic inflammatory distress syndrome (SIRS); pharmaceutical and veterinary preparations for the treatment of adult respiratory distress syndrome (ARDS); pharmaceutical and veterinary preparations for the treatment of inflammatory bowel disease; pharmaceutical and veterinary preparations for the treatment of ulcerative colitis; pharmaceutical and veterinary preparations for the treatment of Crohn's disease; sanitary preparations for medical purposes; dietary supplements for human beings and animals
1 Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry, except fungicides, herbicides, insecticides and parasiticides; biological preparations for use in industry and science
42 Scientific and technological services and research and design relating thereto, namely, scientific research in the field of pharmaceutical studies research, scientific research in new pharmaceutical design services, medical and pharmacological research services, drug discovery services, pharmaceutical drug development services, pharmaceutical research and development; industrial analysis and research services, namely, pharmaceutical analysis and pharmaceutical research
Jan 30, 2024
Final Decision Transaction Processed By Ib
Jan 8, 2024
Final Disposition Notice Sent To Ib
Jan 8, 2024
Final Disposition Processed
Jan 3, 2024
Final Disposition Notice Created, To Be Sent To Ib
Oct 3, 2023
Notice Of Registration Confirmation Emailed
Oct 3, 2023
Registered-Principal Register
Jul 18, 2023
Official Gazette Publication Confirmation E-Mailed
Jul 18, 2023
Published For Opposition
Jun 28, 2023
Notification Of Notice Of Publication E-Mailed
Jun 18, 2023
Refusal Processed By Ib
Jun 15, 2023
Approved For Pub - Principal Register
Jun 14, 2023
Teas/Email Correspondence Entered
Jun 14, 2023
Correspondence Received In Law Office
Jun 14, 2023
Teas Response To Office Action Received
Jun 14, 2023
Teas Change Of Correspondence Received
Jun 14, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 14, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 14, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 14, 2023
Teas Change Of Owner Address Received
May 22, 2023
Non-Final Action Mailed - Refusal Sent To Ib
May 22, 2023
Refusal Processed By Mpu
Mar 31, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Mar 30, 2023
Non-Final Action Written
Mar 24, 2023
Assigned To Examiner
Nov 20, 2022
Notification Of Possible Opposition - Processed By Ib
Aug 9, 2022
Application Filing Receipt Mailed
Aug 4, 2022
New Application Office Supplied Data Entered
Aug 3, 2022
Limitation From Original Application Entered
Jul 28, 2022
Sn Assigned For Sect 66a Subseq Desig From Ib
Trademark Alertz updated from USPTO on 2030-01-24
